Protagonist Therapeutics Inc.

PTGX | NASDAQ

Price Alert Chart Builder DCF Calculator

$144.98

+$1.98 (+1.38%)

At close: Sep 21, 2026, 4:00 PM ET

$144.61

-$0.37 (-0.26%)

Pre-market: Sep 22, 2026, 4:09 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Revenue	46.02M	434.43M	60M	26.58M	27.36M	28.63M
Cost of Revenue	1.23M	n/a	n/a	n/a	n/a	n/a
Gross Profit	44.79M	434.43M	60M	26.58M	27.36M	28.63M
Operating Income	-158.13M	252.84M	-93.65M	-131.37M	-125.85M	-64.52M
Interest Income	28.79M	26.32M	14.9M	4.06M	443K	900K
Pretax Income	-129.31M	279.41M	-78.96M	-127.39M	-125.55M	-64.85M
Net Income	-130.15M	275.19M	-78.96M	-127.39M	-125.55M	-66.15M
Selling & General & Admin	44.85M	43.46M	33.49M	31.74M	27.2M	18.64M
Research & Development	159.29M	138.13M	120.16M	126.22M	126.01M	75.98M
Other Expenses	-1.23M	n/a	n/a	n/a	n/a	-1.48M
Operating Expenses	202.92M	181.59M	153.65M	157.95M	153.2M	93.14M
Interest Expense	n/a	n/a	n/a	n/a	n/a	598K
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	204.14M	181.59M	153.65M	157.95M	153.2M	93.14M
Income Tax Expense	838K	4.22M	n/a	n/a	n/a	1.31M
Shares Outstanding (Basic)	63.57M	61.57M	56.76M	49.04M	46.32M	34.4M
Shares Outstanding (Diluted)	63.57M	65.08M	56.76M	49.04M	46.32M	34.4M
EPS (Basic)	-2.05	4.47	-1.39	-2.52	-2.65	-1.92
EPS (Diluted)	-2.05	4.23	-1.39	-2.52	-2.65	-1.92
EBITDA	-128.09M	280.23M	-75.64M	-124.02M	-122.78M	-63.57M
EBIT	-129.31M	279.41M	-78.96M	-127.39M	-125.55M	-64.52M
Depreciation & Amortization	1.23M	826K	3.31M	3.37M	2.78M	948K